Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20654 | 25829790 | Pharmacognosy Res | Psidium guajava Linn. leaf extract affects hepatic glucose transporter-2 to attenuate early onset of insulin resistance consequent to high fructose intake: An experimental study. | 2015 | Details |
| A20658 | 25824073 | Clin Med (Lond) | Non-alcoholic fatty liver disease: when to intervene and with what. | 2015 | Details |
| A20674 | 25810989 | J Family Med Prim Care | Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians? | 2015 | Details |
| A20682 | 25804931 | J Diabetes Complications | Congestive heart failure presence predicts delayed healing of foot ulcers in diabetes: An audit from a multidisciplinary high-risk foot clinic. | 2015 | Details |
| A20688 | 25798066 | Int J Biol Sci | Stem cell transplantation upregulates Sirt1 and antioxidant expression, ameliorating fatty liver in type 2 diabetic mice. | 2015 | Details |
| A20702 | 25789113 | World J Diabetes | Hepatic glycogenosis: An underdiagnosed complication of diabetes mellitus? | 2015 | Details |
| A20727 | 25773826 | Asian Pac J Cancer Prev | Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes. | 2015 | Details |
| A20734 | 25771129 | Toxicol Appl Pharmacol | Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats. | 2015 | Details |
| A20735 | 25767880 | PLoS One | Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance? | 2015 | Details |
| A20751 | 25755609 | J Clin Exp Hepatol | Risk factors for hepatocellular carcinoma in India. | 2014 | Details |
| A20764 | 25748158 | Nihon Shokakibyo Gakkai Zasshi | [A case of Wilson's disease in an elderly patient initially diagnosed with NASH]. | 2015 | Details |
| A20769 | 25745056 | Arterioscler Thromb Vasc Biol | Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. | 2015 | Details |
| A20775 | 25742316 | Biochem J | Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity. | 2015 | Details |
| A20779 | 25740151 | Biol Rev Camb Philos Soc | De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. | 2015 | Details |
| A20780 | 25739820 | Dig Liver Dis | Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. | 2014 | Details |
| A20796 | 25729707 | Diabetes Metab J | Hepatokines as a Link between Obesity and Cardiovascular Diseases. | 2015 | Details |
| A20799 | 25729475 | World J Hepatol | Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. | 2015 | Details |
| A20800 | 25729473 | World J Hepatol | Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. | 2015 | Details |
| A20806 | 25724480 | Mol Cell Endocrinol | Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? | 2015 | Details |
| A20808 | 25721504 | Science | Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. | 2015 | Details |
| A20810 | 25717238 | World J Gastroenterol | Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. | 2015 | Details |
| A20817 | 25714786 | Metab Syndr Relat Disord | A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20818 | 25714671 | Am J Physiol Endocrinol Metab | Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology. | 2015 | Details |
| A20832 | 25706109 | Curr Drug Targets | Discovery of Novel Anti-Diabetic Drugs by Targeting Lipid Metabolism. | 2015 | Details |
| A20833 | 25705637 | Ann Transl Med | Recent advances in the development of farnesoid X receptor agonists. | 2015 | Details |
| A20836 | 25702656 | Tumori | Fulminant hepatitis in a patient with hepatocellular carcinoma related to nonalcoholic steatohepatitis treated with sorafenib. | 2015 | Details |
| A20839 | 25701721 | Eur J Pharmacol | Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats. | 2015 | Details |
| A20858 | 25683343 | Diabet Med | Practical approach to non-alcoholic fatty liver disease in patients with diabetes. | 2015 | Details |
| A20877 | 25670619 | Arab J Gastroenterol | Effects of fenugreek, Nigella, and termis seeds in nonalcoholic fatty liver in obese diabetic albino rats. | 2015 | Details |
| A20878 | 25669689 | Physiol Res | Peroxisomal enzymes in the liver of rats with experimental diabetes mellitus type 2. | 2014 | Details |
| A20890 | 25659874 | Atheroscler Suppl | The effect of ezetimibe on NAFLD. | 2015 | Details |
| A20908 | 25649191 | Obes Res Clin Pract | Elevation of branched-chain amino acid levels in diabetes and NAFL and changes with antidiabetic drug treatment. | 2015 | Details |
| A20931 | 25633064 | Arch Dis Child | Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists. | 2015 | Details |
| A20943 | 25624725 | World J Gastroenterol | Association of nonalcoholic fatty liver disease and liver cancer. | 2015 | Details |
| A20953 | 25619540 | Curr Diabetes Rev | Is type 2 diabetes mellitus a predisposal cause for developing hepatocellular carcinoma? | 2015 | Details |
| A20975 | 25607821 | Oncol Rep | Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis. | 2015 | Details |
| A21018 | 25574593 | Diabetes Technol Ther | Relationship between β-cell function, metabolic control, and microvascular complications in type 2 diabetes mellitus. | 2015 | Details |
| A21034 | 25564638 | BMJ Case Rep | Resolution of NASH with weight loss documented by hepatic MRI. | 2015 | Details |
| A21048 | 25556679 | Cell Mol Life Sci | Metabolic insights from zebrafish genetics, physiology, and chemical biology. | 2015 | Details |
| A21058 | 29201676 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Disease: Study of Demographic and Predictive Factors. | 2015 | Details |
| A21066 | 27214983 | Eksp Klin Gastroenterol | [INSULIN-LIKE GROWTH FACTOR-1: THE INFLUENCE ON THE LIVER FUNCTION AND RELATIONSHIPS WITH RESISTIN IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND ITS COMBINATION WITH TYPE 2 DIABETES MELLITUS]. | 2015 | Details |
| A21070 | 27051920 | Eksp Klin Farmakol | [EFFECTS OF MELATONIN ON THE ACONITATE HYDRATASE ACTIVITY, CONTENT OF LIPID PEROXIDATION PRODUCTS AND SOME NON-ENZYMATIC ANTIOXIDANTS IN THE BLOOD OF PATIENTS WITH TYPE 2 DIABETES MELLITUS COMPLICATED BY STEATOHEPATITIS]. | 2015 | Details |
| A21076 | 25548491 | World J Gastroenterol | Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. | 2014 | Details |
| A21079 | 25548472 | World J Gastroenterol | Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective. | 2014 | Details |
| A21083 | 25544875 | World J Hepatol | Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. | 2014 | Details |
| A21087 | 25543522 | Clin Res Hepatol Gastroenterol | Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different? | 2014 | Details |
| A21111 | 25533006 | Nutrients | Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight. | 2014 | Details |
| A21126 | 25526792 | BMJ Open | Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetes. | 2014 | Details |
| A21139 | 25521607 | Aliment Pharmacol Ther | The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic. | 2014 | Details |
| A21142 | 25518481 | Eksp Klin Gastroenterol | [Possibilities of using the noninvasive methods of investigating the morphofunctional changes in the liver in patients with non alcoholic steatohepatitis and type 2 diabetes mellitus]. | 2014 | Details |
| A21165 | 25509904 | Ter Arkh | [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease]. | 2014 | Details |
| A21166 | 25509888 | Ter Arkh | [Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity]. | 2014 | Details |
| A21171 | 25502558 | PLoS One | A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet. | 2014 | Details |
| A21187 | 25492998 | World J Gastroenterol | Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A21191 | 25491010 | Eur J Intern Med | The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A21198 | 25484077 | Autophagy | Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway. | 2015 | Details |
| A21230 | 25468829 | Int J Obes (Lond) | Fetuin-A: a novel link between obesity and related complications. | 2014 | Details |
| A21243 | 25459558 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants. | 2014 | Details |
| A21279 | 25436098 | Gastroenterol Hepatol Bed Bench | Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis. | 2014 | Details |
| A21281 | 34860874 | J Pharm Technol | Past, Present, and Future Research Avenues for Metformin: A Literature Review. | 2014 | Details |
| A21282 | 28664097 | Integr Med Res | Practical approaches to the nutritional management of nonalcoholic fatty liver disease. | 2014 | Details |
| A21292 | 25429378 | Scand J Gastroenterol | Noninvasive characterization of graft steatosis after liver transplantation. | 2014 | Details |
| A21301 | 25422733 | Iran J Neurol | Association between non-alcoholic fatty liver disease and ischemic stroke. | 2014 | Details |
| A21310 | 25414939 | Postgrad Med | Diabetes mellitus as a novel risk factor for gastrointestinal malignancies. | 2014 | Details |
| A21312 | 25413450 | Metab Brain Dis | Low-grade chronic inflammation induces behavioral stereotypy in rats. | 2014 | Details |
| A21315 | 25412688 | Curr Vasc Pharmacol | Incretin-Based Antidiabetic Agents for the Management of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A21323 | 25405502 | J Clin Endocrinol Metab | Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes. | 2014 | Details |
| A21335 | 25399255 | BMC Genomics | A network biology workflow to study transcriptomics data of the diabetic liver. | 2014 | Details |
| A21336 | 25395147 | Ann Surg Oncol | Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection. | 2014 | Details |
| A21340 | 25390016 | Horm Mol Biol Clin Investig | The pathophysiology of abdominal adipose tissue depots in health and disease. | 2014 | Details |
| A21344 | 25386164 | Front Endocrinol (Lausanne) | Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments. | 2014 | Details |
| A21370 | 25371150 | J Cell Biochem | The hepatic transcriptome of young suckling and aging intrauterine growth restricted male rats. | 2015 | Details |
| A21384 | 25356056 | World J Gastroenterol | Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease. | 2014 | Details |
| A21385 | 25356042 | World J Gastroenterol | Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation. | 2014 | Details |
| A21396 | 25350950 | J Diabetes | Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study. | 2014 | Details |
| A21400 | 25348993 | Br J Gen Pract | Ethnicity and the diagnosis gap in liver disease: a population-based study. | 2014 | Details |
| A21409 | 25343462 | PLoS One | Association between serum irisin levels and non-alcoholic fatty liver disease in health screen examinees. | 2014 | Details |
| A21457 | 25307311 | Mini Rev Med Chem | Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome. | 2014 | Details |
| A21462 | 25303488 | J Clin Endocrinol Metab | High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. | 2014 | Details |
| A21468 | 25298375 | Eur J Endocrinol | External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. | 2014 | Details |
| A21473 | 25296075 | Arq Gastroenterol | Age and gender may influence the results of Roux-en-Y gastric bypass? Metabolic syndrome parameters. | 2015 | Details |
| A21478 | 25293867 | Eur J Clin Invest | Nonalcoholic fatty liver disease vs. obesity on the risk of erosive oesophagitis. | 2014 | Details |
| A21492 | 25281760 | J Lipid Res | Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance. | 2014 | Details |
| A21511 | 25266069 | J Diabetes | Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth. | 2014 | Details |
| A21512 | 25265201 | Nanotoxicology | Intratracheal exposure to multi-walled carbon nanotubes induces a nonalcoholic steatohepatitis-like phenotype in C57BL/6J mice. | 2014 | Details |
| A21527 | 25252298 | Anatol J Cardiol | Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography. | 2014 | Details |
| A21535 | 25246029 | Acta Diabetol | Genome-wide analysis of hepatic lipid content in extreme obesity. | 2014 | Details |
| A21536 | 25245380 | Curr Med Chem | Association between polycystic ovary syndrome and metabolic syndrome. | 2014 | Details |
| A21537 | 25245142 | J Proteome Res | Serum metabolite signatures of type 2 diabetes mellitus complications. | 2014 | Details |
| A21539 | 25243967 | Zhonghua Gan Zang Bing Za Zhi | [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus]. | 2014 | Details |
| A21541 | 25242225 | Cell Metab | Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. | 2014 | Details |
| A21577 | 25216184 | PLoS One | Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores. | 2014 | Details |
| A21593 | 25198445 | Pediatr Ann | Screening for metabolic and reproductive complications in obese children and adolescents. | 2014 | Details |
| A21603 | 25194178 | Best Pract Res Clin Gastroenterol | Mechanisms behind the link between obesity and gastrointestinal cancers. | 2014 | Details |
| A21613 | 25186086 | Aliment Pharmacol Ther | Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia. | 2014 | Details |
| A21614 | 25185870 | Aliment Pharmacol Ther | End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndrome. | 2014 | Details |
| A21626 | 30736212 | Expert Rev Endocrinol Metab | Non-alcoholic fatty liver disease in patients with diabetes mellitus. | 2014 | Details |
| A21627 | 25171027 | Eur J Gastroenterol Hepatol | A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease. | 2014 | Details |
| A21635 | 25164277 | Expert Opin Investig Drugs | GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes. | 2014 | Details |
| A21659 | 25143715 | Clin Interv Aging | Nonalcoholic fatty liver disease (NAFLD) - a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients. | 2014 | Details |